Upcoming Login Downtime

We're updating the Biocentury.com platform login experience to make access more secure and reliable. As part of this update, logins will be temporarily unavailable on Sunday, March 16, from 4:00AM to 4:00PM GMT. We recognize the inconvenience and appreciate your understanding. Please check back after the maintenance period.

For updates, questions, or issues, please call us at +1 650-552-4224 or email us at support@biocentury.com.

BioCentury
ARTICLE | Distillery Therapeutics

Targeting ARHGAP11A for Alzheimer's disease

July 18, 2023 8:55 PM UTC

Targeting the Ras homolog ARHGAP11A could help treat Alzheimer's disease by decreasing expression of disease-associated proteins and induction of apoptosis.

Analysis of publicly available data sets showed hippocampal ARHGAP11A mRNA levels were higher in patients with Alzheimers's disease than healthy elderly controls, and serum protein levels of ARHGAP11A were higher in patients with mild cognitive impairment than healthy controls, with even higher levels in Alzheimer's patients. In a genetic mouse model of Alzheimer's disease, brain levels of ARHGAP11A protein were higher than in wild-type mice. ...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article